BMY241220C58000
- 0.01
- 0.000.00%
Bristol-Myers Squibb Newsroom
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Fund Update: Dakota Wealth Management Just Disclosed New Holdings
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Express News | 'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Bristol-Myers Squibb (NYSE:BMY) Places Faith In Cobenfy for Alzheimer's Treatment
Express News | U.S. Says Other Drugs on Medicare Drug Price List Include Pomalyst, Ibrance and Calquence
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
Wall Street Today: JPM and Banking Leads Market Higher
Live Stock: Banks Break the Bank on Earnings, Inflation Looks Tame for Dec
Positive Outlook for Bristol-Myers Squibb With Promising Market Access and Societal Benefits of Cobenfy
Wall Street Today: Market Barely Climbs, Wholesale Inflation Grows Less Than Feared
Live Stock News: Tuesday Market Climbs and TikTok Sale Might be Incoming
Bristol-Myers Squibb Company's (NYSE:BMY) Business And Shares Still Trailing The Industry
SNY's Subcutaneous Sarclisa Proves Non-Inferior to IV Formulation (Revised)
Bristol Myers Squibb CEO Describes New Drug for Treating Schizophrenia
Wall Street Today: Market Turns Around, Let's See if it Lasts
Bristol Sees Annual $1.5B in Cost Savings by End of 2025